Journal
AUTOIMMUNITY REVIEWS
Volume 9, Issue 8, Pages 583-587Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.autrev.2010.04.003
Keywords
PD-1; Gender; Sex hormones; Autoimmunity; Systemic lupus erythematosus; Immune system
Categories
Funding
- NIH [AR54034, AI083894, AI65645, AI46776]
- UCLA
- Southern California Arthritis Foundation (SCAF)
Ask authors/readers for more resources
Programmed death 1 (PD-1) and its ligands (PD-L1 and PD-L2) are responsible for inhibitory T cell signaling that helps mediate the mechanisms of tolerance and immune homeostasis. The PD-1:PD-L signaling pathway has been shown to play an important role in a variety of diseases, including autoimmune conditions, chronic infection, and cancer. Recently, investigators have explored the role of sex hormones in modulating the pathway in autoimmune conditions. Exploring the effects of sex hormones on the PD-1:PD-L pathway could shed light on the gender biased nature of many autoimmune conditions as well as aide in the development of therapeutics targeting the immune system. (C) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available